Devise fiat
Crypto-monnaies
Aucun résultat pour ""
Nous n'avons rien trouvé qui corresponde à votre recherche. Réessayez avec d'autres mots-clés.
NewLimit - Series A
Vue d'ensemble
À propos de la NewLimit - Series A
Investisseur
Investisseurs | Taper | Emplacement | Année de fondation | #Sociétés du portefeuille | Adresse e-mail | Social |
---|---|---|---|---|---|---|
Fund | United States of America | -- | 1 | -- | ||
Fund | United States of America | 1972 | 15 | [email protected] | ||
Fund | United States of America | 2005 | 36 | [email protected] | ||
Angel Investor | -- | -- | 2 | -- | ||
Angel Investor | United States of America | -- | 7 | -- |
Fondateurs & Équipe
Brian Armstrong
Greg Johnson
Jacob Kimmel
Profil de l'entreprise / Introduction du projet
NewLimit was founded to cure aging. They are working toward this goal by uncovering sets of transcription factors that can epigenetically reprogram cells. Although its products are designed to treat aging itself, NewLimit also believe these products could treat or prevent many diseases associated with aging, including fibrosis, infectious disease, and neurodegenerative disease.